Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jinwon Jung
Institution:
ABL Bio (South Korea)
Observed institution:
ABL Bio (South Korea)
ORCID:
0000-0002-7981-3316
Observed ORCID:
0000-0002-7981-3316
OpenAlex ID:
A5124765511
ABL209 (NEOK002): Designing an EGFR × MUC1 Bispecific TOP1i ADC with Promising Antitumor Activity and Enhanced Therapeutic Window
2026
·
Bora Lee
, Hyeon Ji Park
, et al.
·
Molecular Cancer Therapeutics
·
1
Systemic and local delivery of siRNA to the CNS and periphery via anti-IGF1R antibody conjugation
2026
·
Mengnan Tian
, Mehran Nikan
, et al.
·
Molecular Therapy — Nucleic Acids
Abstract 1726: NEOK002 (ABL209): Redesigning an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic window
2026
·
Bora Lee
, Hyeon Ji Park
, et al.
·
Cancer Research
Abstract 1724: NEOK001 (ABL206): A first in class B7-H3xROR1 bispecific ADC demonstrated enhanced efficacy and promising tolerability
2026
·
Min Ji Ko
, Junga Kwon
, et al.
·
Cancer Research
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
